Thermo Fisher soars in Q4; Vycor launches Class I recall of brain surgery device;

 @FierceMedDev: Startup brings molecular diagnostics to India's swelling market. Article | Follow @FierceMedDev

 @MarkHFierce: Today's Dx Extra: Another company will take on development of an RA Dx. Story | Follow @MarkHFierce

 @DamianFierce: After a weak Q4, Zimmer's counting on restructuring to save 2013 profits. News | Follow @DamianFierce

> Thermo Fisher ($TMO) posted a record $3.26 billion in fourth-quarter revenue, a 6% jump over the same period in 2011. Results

> Vycor Medical has launched a Class I recall of some of its Viewsite brain access devices, warning of serious adverse events including death. More

> California's Velomedix has enrolled the first patient in a trial of its device that works to cool the peritoneal cavity during myocardial infarction procedures. Release

> As more and more cancer drugs come paired with companion diagnostics, Dx companies are cashing in and advancing the field. Article

> Arteriocyte got the FDA's sign-off to launch a trial of its Magellan device to treat thermal burn wounds. Item

Biotech News

 @FierceBiotech: Celsion shares routed after PhIII liver cancer study flops. News | Follow @FierceBiotech

@JohnCFierce: AstraZeneca's Soriot is going to have to do something bold, something dramatic, and something a little loony. In that order. | Follow @JohnCFierce

@RyanMFierce: Holland's health minister is sounding very German on drug pricing, wants to chop cost of Genzyme and Shire therapies. More | Follow @RyanMFierce

> Venture firm preps $100M fund for late-stage life sciences investments. News

> Vanda slides after drug fails PhII/III for depression. Item

> Is AstraZeneca getting ready to buy a pipeline? Report

> Pharmaxis suffers FDA committee upset, nabs up to $40M in financing. Article

> Genentech flashes PhIII progress for prized Rituxan successor. Story

Pharma News

@FiercePharma: EMA sounds a bit perturbed about France's suspension of Diane-35. But it will review data when France asks. More | Follow @FiercePharma

 @AlisonBFierce: Life Technologies established an international flu network to develop a speedy monitoring system and better vaccine. News | Follow @AlisonBFierce

@EricPFierce: BASF says it has finally gotten the Pronova deal closed making it one of the largest fish oil producers in the world. Release | Follow @EricPFierce

> Novo meets 'sky-high' expectations with 18% sales growth. Report

> Genzyme's $176K Kynamro price undercuts its $250K-plus rival. Article

> Patent Cliff II: Nightmare on blockbuster street returns in 2015. News

Vaccines News

> MIT explores DNA vaccine delivery. Item

> Life establishes international flu network. More

> CDC: Adult vaccination rates 'unacceptably low.' Report

> FDA expands use of Pfizer's Prevnar 13. Article

> GSK, Biological E partner on childhood vaccine. Story

Pharma Manufacturing News

> Cargo theft up dramatically in Mexico. Item

> Sanofi's Genzyme looking hard at continuous manufacturing. News

> Biogen, Merck, Novartis, others have plants recognized for innovations. More

> Teva, P&G start on OTC plant in India. Story

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.